Switch to:
More From Other Websites
5 Companies That Destroyed Shareholders Last Week May 01 2016
Will Sarepta Therapeutics (SRPT) Stock Be Hurt by Jefferies Downgrade? Apr 29 2016
Jefferies Cuts Sarepta To Sell, Sees Little Chance Of FDA Approval Apr 29 2016
Top Analyst Upgrades and Downgrades: Amazon, Ford, Gilead, Level 3, Sarepta, Western Digital,... Apr 29 2016
Sarepta: FDA Policy Forced AdCom To Vote Against Patients' Interests Apr 29 2016
Sarepta Therapeutics downgraded by Jefferies Apr 29 2016
[$$] Mental Dystrophy at the FDA Apr 28 2016
[$$] Mental Dystrophy at the FDA Apr 28 2016
Sarepta Jumps On Hopes For Muscular Dystrophy Drug Apr 28 2016
Is XBI Heading Back to Where It Started in April? Apr 28 2016
Why Are Investors Piling Into These Surging Stocks? Apr 28 2016
Jim Cramer -- Will FDA Approve Sarepta's Duchenne Drug After All? Apr 28 2016
Sarepta Can Win Speedy FDA Drug Approval Apr 28 2016
The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead Apr 28 2016
Cramer's Mad Dash: Sarepta & PayPal Apr 28 2016
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible Apr 28 2016
Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News Apr 27 2016
Small Cap Watch: These 4 Stocks Are Making Big Moves Today Apr 27 2016
These Five Stocks Could Be Ready To Double – Here’s Why! Apr 27 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK